29
DAFTAR PUSTAKA
Anderson, I., 2000. Review : selective serotonin reuptake inhibitors are as effective as tricyclic antidepressants overall but may be less effective in some patient subgroups. Affect Disord 3, 2000.
Barton, M.K., 2011. Drug interactions in cancer patients receiving antidepressants are common, researchers report. CA. Cancer J. Clin. 61, 283–284.
Bentue-Ferrer, D., Reymann, J., Tribut, O., Allain, H., Vasar, E., Bourin, M., 2001. Role of dopaminergic and serotonergic systems on behavioral stimulatory effects of low-dose alprazolam and lorazepam. Eur Neuropsychopharmacol 11, 41–5.
Bishop, J.R., and Bishop, D.L., 2011. How to prevent serotonin syndrome from drug-drug interactions. Curr. Psychiatr. 10, 81–83.
Coelho, P.V., and Brum, C.D.A., 2009. Interactions between antidepressants and antihypertensive and glucose lowering drugs among patients in the HIPERDIA Program, Coronel Fabriciano, Minas Gerais State, Brazil. Cad. saude publica / Minist. da Saude, Fund. Oswaldo Cruz, Esc. Nac. Saude Publica 25, 2229–2236.
Cooper, B.E., and Sejnowski, C.A., 2013. serotonin syndrome : Recognition and Treatment. AACN Adv. Crit. Care 24, 15–20.
Darmayanti, N., 2002. Meta Analisis : Gender Dan Depresi Pada Remaja 35, pp. 164–180.
Evoy, G.K.M., 2008. American Society of health-system pharmacists formulary service. Bethesda.
Ewald Howarth, Wainberg, M., Cournos, F., 2004. Psychiatric Medications and HIV Antiretrovirals : A Guide to Interactions For Clinical. In: NY/NJ AETC and the Columbia University HIV Mental Health Training Project.
Feighner, J., 1999. Mechanism of Action of Antidepressant Medications. J Clin Psychiatry 4, 11.
Fuller, M., and Sajatoviv, M., 2002. Drug Information Handbook for Psychiatry. Lexy Comp, Kanada.
Ganiswara, S.G., 2008. Farmakologi dan Terapi Edisi 5. FKUI, Jakarta.
30
Gupta, S.K., Shah, J.C., Hwang, S.S., 1999. Pharmacokinetic and pharmacodynamic characterization of OROS A and immediate-release amitriptyline 71–78.
Hansten, philip D., and Horn, J.R., 2000. Managing Clinically Important Drug Interactions. Fact & Comparisions.
Helmyati, S., Rahmawati, Nur Farida, Purwanto, Yuliati, E., 2014. Interaksi Obat dan Makanan. Gajah Mada University Press, Yogyakarta.
Hoan, T.T., Rahardja, K., 2015. Obat-obat Penting Khasiat, Penggunaan dan Efek-efek Sampingnya, Edisi 7. ed. Pt. Gramedia, Jakarta.
Italiano, D., Spina, E., de Leon, J., 2014. Pharmacokinetic and pharmacodynamic interactions between antiepileptics and antidepressants. Expert Opin. Drug Metab. Toxicol. 10, 1457–89.
Kando, J.C., Teter, C.S., Wells, B.G., Hayes, P.E., 2007. Depressive Disorder Pharmacoth. ed. Appleton and lange, New York.
Keller, M.B., and Shapiro, R.W., 1981. Major Depressive Disorder. J. Nerv. Ment. Dis. 169, 761–768.
Lynch, T., and Price, A., 2007. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am. Fam. Physician 76, 391–396.
Mann, J.J., 2005. The medical management of depression. N. Engl. J. Med. 353, 1819–1834.
Medscape, 2015. Drug Interaction Cheker. online. URL http://www.reference.medscape.com/drug-interactionchecker
Mental, H., 2011. Graylands Hospital Drug Bulletin Cytochromes and Psychotripics. North Metrop. Area Heal. Serv. 18.
Mental, S., Hasharon, H., Mental, G., 2001. Post-Psychotic Depression in Schizophrenia 3, 589–592.
Miguel, C., and Albuquerque, E., 2011. Drug interaction in psycho-oncology: Antidepressants and antineoplastics. Pharmacology 88, 333–339.
Mihaljevic-Peles, A., Sagud, M., Bozina, N., Zivkovic, M., Jovanovic, N., 2009. Pharmacogenetics and interactions of antidepressants in the treatment of co-morbid illness. Psychiatr. Danub. 21, 399–400.
31
Naibaho, D., 2008. Hubungan Interval QTc Memanjang Dengan Derajat Disfungsi Hati pada. Uviversitas Sumatera Utara.
Notoatmodjo, S., 2005. Metode Penelitian Kesehatan. PT. Rineka Cipta, Jakarta.
Nugroho, A.E., 2012. Farmakologi: Obat-obat Penting dalam Pembelajaran Ilmu Farmasis dan Dunia Kesehatan. Pustaka Belajar, Yogyakarta.
Okiyama, M., Ueno, K., S, O.I.T., Kitagawa, H., 1987. Drug interactions between imipramine and benzodiazepines in rats. US Natl. Libr. Med. Natl. Institutes Heal. 77(1):56-6.
Pieter, H.Z., Janiwarti, B., Ns. Marti Saragih, 2011. Pengantar Psikopatologi untuk Keperawatan. Kencana, Jakarta.
Prayitno, 2008. Farmakologi Dasar. Lenskopi, Jakarta. pp.23.
Rahmawati, F., Handayani, R., Gosal, V., 2006. Kajian Retrospektif Interaksi Obat di Rumah Sakit Pendidikan Dr. SardjitoYogyakarta. Maj. Farm. Indones. 17, pp. 177–183.
Rao, N., 2007. The Clinical Pharmakokinetics of Escitalopram. Clin. Pharmacokinet 46, 281–90.
Rasheed, A., Javed, M., Nazir, S., Khawaja, O., 1994. Interaction of chlorpromazine with tricyclic anti-depressants in schizophrenic patients. J Pak Med Assoc 44, 233–4.
Reus V.I., 2004. Mood Disorders dalam : Review of General Psychiatry. McGraw Hill, Singapore. pp.27-35.
Sari, A., Wahyono, D., Raharjo, B., 2012. Identification Of Potential Drug Interactions In Ward Patients At Margono Soekarjo Purwokerto ’S Hospital : A Retrospective Observation. J. Ilm. Kefarmasian 2.
Sharpley, A.L., Vassallo, C.M., Cowen, P.J., 2000. Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT(2C) receptors in vivo. Biol Psychiatry 47, 468–470.
Snyder, B., Polasek, T., Doogue, M., 2012. Drug interactions: principles and practice. Australian Prescriber.
Spina, E., and De Leon, J., 2007. Metabolic drug interactions with newer antipsychotics: A comparative review. Basic Clin. Pharmacol. Toxicol. 100, 4–22.
32
Surbakti, R. br, 2014. Case Report A 30 Years Old Man With Depressed Type Of Schizoaffective Disorder. J Medula Unila 3, 89–95.
Syamsudin, 2011. Interaksi Obat Konsep Dasar dan Klinis. Universitas Indonesia (UI-Press), Jakarta.
Tatro, D., 2001. Drug Interaction Fact 6Ty edition, Facts Comparison. a Wolter Kluwers, St Louis.
Tatro, D.., 2009. Drug Interaction Fact The Autority Drug Interactions, Fact And Comparison. Wolter Kluwers, St Louis.
Teles, J.S., Fukuda, E.Y., Feder, D., 2012. Warfarin: pharmacological profile and drug interactions with antidepressants. Einstein (São Paulo) 10, 110–115.
Unutzer, J., 2007. Late-Life Depression. N. Engl. J. Med. 2269–2276.
Walzer, M., Bekersky, I., Blum, R., Tolbert, D., 2012. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes. Pharmacotherapy 32, 340–53.
Wenzel-Seifert, K., Wittmann, M., Haen, E., 2011. QTc prolongation by psychotropic drugs and the risk of Torsade de Pointes. Dtsch. Arztebl. Int. 108, 687–93.
Yap, G., and Camm, A., 2003. Drug induced QT prolongation and Torsades de Pointes. Heart 89, 1363–1372.
Yosep, I., 2010. Keperawatan Jiwa (Edisi Revisi). PT Refika Aditama, Bandung.
Young, C.R., Bowers, M.B., Mazure, C.M., 1998. Management of the adverse effects of clozapine. Schizophr. Bull. 24, 381–390.
